CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients
Open Access
- 3 January 2025
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 74 (2) , 1-10
Abstract
Cytomegalovirus (CMV) infection or reactivation in immune-compromised individuals can lead to a wide range of severe complications including hepatitis. However, its relation with immune checkpoint inhibitors (ICIs) induced hepatitis (ICI-hepatitis) and tumor responses in advanced melanoma patients remains unclear. Hundred and ninety metastatic cutaneous melanoma patients (mCM) who received ICI treatment, with CMV IgG or IgM information available at baseline, were included in the study (Cohort 1). Clinical characteristics and immune cell count in the blood were retrieved from medical records. In addition, anti-CMV IgG and IgM were measured in pre and on-treatment serum samples from 49 advanced skin cancer patients using ELISA (Cohort 2). In the event of a positive anti-CMV IgM, further analysis with PCR was performed. Univariate and multivariate analysis was used to assess the relationship between CMV IgG or IgM and ICI-hepatitis tumor outcomes. Twenty-one patients (11%) developed hepatitis during ICI treatment (Cohort 1). ICI-hepatitis was significantly associated with disease control rate (DCR; p = 0.017) and longer progression-free survival (PFS; p = 0.008) in mCM patients. Detection of CMV IgG or IgM antibodies were not associated with ICI-hepatitis (p > 0.05). However, increased CMV IgG values at baseline correlated with disease progression (p = 0.047) and shorter PFS (p = 0.081). In addition, increased CMV IgG values were associated with reduced levels of monocytes (p = 0.005), eosinophils (p = 0.062), and neutrophils (p = 0.065) in the blood. In summary, anti-CMV IgG or IgM in the blood may not be associated with ICI-hepatitis, but high anti-CMV IgG at baseline indicates poor outcomes in ICI-treated mCM patients.Keywords
Funding Information
- Medizinische Fakultät Heidelberg der Universität Heidelberg
This publication has 35 references indexed in Scilit:
- Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell toleranceHepatology, 2007
- PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosisJournal of Hepatology, 2006
- Acute and chronic hepatitisSeminars in Diagnostic Pathology, 2006
- Management of CMV infection and disease in transplant patients. 27-29 February 2004.2004
- Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progressionFEMS Microbiology Reviews, 2004
- Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections.2003
- Loss of cytomegalovirus-specific immunological memory in a patient with thymomaClinical and Experimental Immunology, 2002
- Hepatocytes are Permissive for Human Cytomegalovirus Infection in Human Liver Cell Culture and In VivoThe Journal of Infectious Diseases, 1999
- Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.1998
- Modulatory Effects of Human Cytomegalovirus Infection on Malignant Properties of Cancer CellsIntervirology, 1996